Elucid Labs is a MedTech company developing augmented intelligence imaging solution for early detection and diagnosis of skin cancer. Its proprietary imaging technology probes the molecular makeup of the skin at different layers and produces an unique fingerprint for the mole/lesion. The company has developed a proprietary AI technology translates this fingerprint into valuable clinical informatics to assist dermatologists in making better, faster, and more well informed decisions. With its technology, detection and diagnosis of skin cancer can be performed at much earlier stages of development which in turn reduces the cost of treatment as well as significantly reducing the unnecessary biopsies carried out every year.